Early access
Sign in
Taking peopleNo phase

Imaging to sort giant cell arteritis and polymyalgia rheumatica by disease course

Studies whether new imaging can sort people with giant cell arteritis or polymyalgia rheumatica.

Key facts

Who runs it
Aarhus University Hospital
Where
Denmark2 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
DANIsh VASculitis Database (DANIVAS)
Status
Recruiting
People taking part
3,000 people, planned
Started
10 Nov 2023
Expected to end
31 Dec 2051
Type of study
Observational
Record updated
24 January 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR) diagnosed in the last 5 years. It studies whether new imaging scans can help guide care.

Age
50 Years and older
Sex
All sexes
Disease stage
GCA or PMR diagnosed within the last 5 years. A rheumatologist must have made or confirmed the diagnosis.

Main reasons for not taking part

  • People who refuse or are not able to give informed consent cannot join.
  • People with another whole-body autoimmune disease that rules out GCA or PMR cannot join.
  • People who do not speak and understand Danish cannot join.

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Are diagnosed with GCA or PMR within the last 5 years
  • Diagnosis is established by or confirmed by a rheumatologist (clinical expert opinion)
  • Speak and understand Danish
  • Are able to give signed and dated informed consent

Who cannot take part

  • Are diagnosed with other systemic autoimmune diseases that out-rules the diagnosis of GCA or PMR
  • Denies or are not able to give informed consent

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this national pragmatic observational study is to investigate whether the use of new diagnostic imaging modalities facilitates disease stratification that can potentially predict treatment response, relapse risk and complications and hence guide management strategies to improve disease control and reduce disease and treatment related damage.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Disease Stratification in GCA and PMR to Inform Management and Reduce Disease and Treatment-related Damage
Plain-language title
Imaging to sort giant cell arteritis and polymyalgia rheumatica by disease courseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
24 January 2024